Why I’d Buy Polypipe Group PLC, Watch Reckitt Benckiser Group Plc And Sell BT Group plc

While Polypipe Group PLC (LON: PLP) has huge investment potential and Reckitt Benckiser Group Plc (LON: RB) is a top quality stock, BT Group plc (LON: BT.A) looks set to disappoint

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in plastic piping specialist Polypipe (LSE: PLP) have risen by as much as 7% today after the company announced the acquisition of ventilation systems manufacturer, Nuaire, for £145m. The deal will be fully paid for in cash, with Polypipe utilising existing cash balances on its balance sheet as well as new debt to fund the deal.

Clearly, the market has warmly received the news and, with Nuaire expanding Polypipe’s product platform and market reach within the growing ventilation sector, it seems to make sense for the company’s long term growth outlook. Furthermore, Nuaire posted a rise in revenue of 18.8% in its last full financial year, as well as an increase in operating profit of 29.4%, and so it is likely to make a positive contribution to Polypipe’s financial numbers in the short to medium term.

Looking ahead, Polypipe appears to have huge capital gain potential even though its shares have already risen by 28% since the turn of the year. That’s because it is expected to grow its bottom line by 13% this year, followed by further growth of 16% next year. Such a strong growth rate is likely to positively catalyse investor sentiment in the company and, with Polypipe’s shares trading on a price to earnings growth (PEG) ratio of just 0.9, they appear to offer excellent value for money.

In fact, when compared to consumer goods company Reckitt Benckiser (LSE: RB), the difference in growth prospects over the medium term is staggering. For example, Reckitt Benckiser is expected to grow its bottom line by just 3% this year and by a further 7% next year. Although these are not particularly low numbers, Reckitt Benckiser’s PEG ratio of 3.4 indicates that its shares are overvalued at the present time.

Certainly, it is an excellent business with huge long term growth potential across the developing world. However, much of this appears to be more than adequately priced in. As such, Reckitt Benckiser appears to be worth adding to a watch list until such time as its shares offer more appealing value for money.

Meanwhile, BT (LSE: BT-A) also lacks value at the present time, with its shares trading on a PEG ratio of 2.7 as a result of growth of just 1.9% being forecast over the next two years. And, while the company is enduring a transitional period that could increase its dominance of the quad play market (and lead to higher margins in the long run), the nearer term outlook for the business appears to be very challenging. As well as a high (and increasing) level of competition, BT is also investing heavily in sports rights and in attempting to win customers, both of which are set to hurt its profitability in the current year.

So, while Polypipe appears to be well-worth buying at the moment and Reckitt Benckiser is worth keeping an eye on in case its price becomes more appealing, BT seems to be a stock to avoid.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Why I’ve just sold two of the largest investments in my Stocks and Shares ISA

Stephen Wright has been making room for a new addition to his Stocks and Shares ISA. What is it and…

Read more »

Investing Articles

2 UK shares I’m avoiding like the plague in today’s stock market

Stephen Wright is a big fan of UK shares. But both the FTSE 100 and the FTSE 250 contain companies…

Read more »

Investing Articles

With yields over 8.8%, which of the FTSE 100’s top 5 passive income stocks do I think is the best?

These five passive income stocks are all yielding more than 8.8%. Our writer considers which of them (if any) would…

Read more »

Investing Articles

At 538p, is the Rolls-Royce share price really that expensive?

The Rolls-Royce share price has continued its incredible post-pandemic rally causing many to ask whether the stock’s overvalued. Our writer…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

The best investment quote of all time didn’t come from Warren Buffett!

Warren Buffett’s pithy quotes are both relevant and insightful. But the American billionaire didn’t come up with our writer’s favourite.

Read more »

Investing Articles

Down 13.7% in 7 days, what’s going on with the Lloyds share price?

Our writer looks at recent movements in the Lloyds share price. And asks whether now could be a good time…

Read more »

Dividend Shares

Here’s a simple 5-stock dividend income portfolio with a 7.5% yield

With these five British dividend stocks, one could potentially generate income of around £750 per year from a £10,000 investment.

Read more »

Investing Articles

If I’d put £10,000 into the FTSE 100’s biggest stock at the start of 2024, here’s what I’d have now

The FTSE 100’s biggest company has romped away from the index over the last five years, but has fallen behind…

Read more »